Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Br J Cancer ; 94(8): 1194-203, 2006 Apr 24.
Article in English | MEDLINE | ID: mdl-16538220

ABSTRACT

Spontaneous and radiation-induced genetic instability of peripheral blood mononuclear cells derived from unselected breast cancer (BC) patients (n=50) was examined using the single-cell gel electrophoresis (Comet) assay and a modified G2 micronucleus (MN) test. Cells from apparently healthy donors (n=16) and from cancer patients (n=9) with an adverse early skin reaction to radiotherapy (RT) served as references. Nonirradiated cells from the three tested groups exhibited similar baseline levels of DNA fragmentation assessed by the Comet assay. Likewise, the Comet analysis of in vitro irradiated (5 Gy) cells did not reveal any significant differences among the three groups with respect to the initial and residual DNA fragmentation, as well as the DNA repair kinetics. The G2 MN test showed that cells from cancer patients with an adverse skin reaction to RT displayed increased frequencies of both spontaneous and radiation-induced MN compared to healthy control or the group of unselected BC patients. Two patients from the latter group developed an increased early skin reaction to RT, which was associated with an increased initial DNA fragmentation in vitro only in one of them. Cells from the other BC patient exhibited a striking slope in the dose-response curve detected by the G2 MN test. We also found that previous RT strongly increased both spontaneous and in vitro radiation-induced MN levels, and to a lesser extent, the radiation-induced DNA damage assessed by the Comet assay. These data suggest that clinical radiation may provoke genetic instability and/or induce persistent DNA damage in normal cells of cancer patients, thus leading to increased levels of MN induction and DNA fragmentation after irradiation in vitro. Therefore, care has to be taken when blood samples collected postradiotherapeutically are used to assess the radiosensitivity of cancer patients.


Subject(s)
Breast Neoplasms/radiotherapy , Comet Assay/methods , Leukocytes, Mononuclear/radiation effects , Adolescent , Adult , Aged , Breast Neoplasms/genetics , DNA Damage , DNA Repair , Dose-Response Relationship, Radiation , Female , Humans , In Vitro Techniques , Leukocytes, Mononuclear/pathology , Male , Micronucleus Tests/methods , Middle Aged , Predictive Value of Tests , Radiation Tolerance , Risk Factors , Sensitivity and Specificity , Severity of Illness Index , Skin/pathology , Skin/radiation effects , X-Rays
2.
Biol Chem ; 382(5): 859-65, 2001 May.
Article in English | MEDLINE | ID: mdl-11517942

ABSTRACT

Folding of cathepsins L and S depend upon their proregion which extends the enzyme part by about 100 amino acids. Only a minority of the prosequence follows the structural template provided by the enzyme part; the majority forms an autonomous minidomain fairly distant from the active site cleft. We suggest that this prodomain may be the structural correlate of a foldase function of the proregion within the cathepsin L-like subfamily of papain-type cysteine proteases and report on a functional approach supporting this hypothesis.


Subject(s)
Cysteine Endopeptidases/chemistry , Enzyme Precursors/chemistry , Models, Chemical , Protein Folding , Cathepsin L , Cathepsins , Conserved Sequence , Cysteine Endopeptidases/genetics , Cysteine Endopeptidases/metabolism , Humans , Kinetics , Mutagenesis , Protein Structure, Tertiary
3.
Am J Pathol ; 158(5): 1571-8, 2001 May.
Article in English | MEDLINE | ID: mdl-11337353

ABSTRACT

Chordoma is the fourth most common malignant primary neoplasm of the skeleton and almost the only one showing a real epithelial phenotype. Besides classic chordoma, so-called chondroid chordoma was described as a specific entity showing cartilage-like tissue within chordomatoid structures. However, since its first description, strongly conflicting results have been reported about the existence of chondroid chordoma and several studies suggested chondroid chordomas being in fact low-grade conventional chondrosarcomas. In the present study, we used cytoprotein expression profiling and molecular in situ localization techniques of marker gene products indicative of developmental phenotypes of chondrocytes to elucidate origin and biology of chondroid chordoma. We were able to demonstrate the chondrogenic potential of chordomas irrespectively of the appearance of overt cartilage formation by identifying the multifocal expression of type II collagen, the main marker of chondrocytic differentiation. Additionally, the cartilage-typical large aggregating proteoglycan aggrecan was present throughout all chordomas and, thus, a very characteristic gene product and marker of these neoplasms. Biochemical matrix composition and cell differentiation pattern analysis showed a high resemblance of classic chordomas and in chordoid areas of chondroid chordomas to the fetal chorda dorsalis, whereas chondroid areas of chondroid chordomas showed features similar to adult nucleus pulposus. This demonstrates on the cell function level the chondrocytic differentiation potential of neoplastic chordoid cells as a characteristic facet of chordomas, mimicking fetal vertebral development, ie, the transition of the chorda dorsalis to the nucleus pulposus. Our study firmly establishes a focal real chondrocytic phenotype of neoplastic cells in chordomas. Chondroid chordoma is neither a low-grade chondrosarcoma nor a misnomer as discussed previously.


Subject(s)
Cell Differentiation , Chordoma/genetics , Extracellular Matrix Proteins/genetics , Intervertebral Disc/pathology , Aggrecans , Chordoma/metabolism , Chordoma/pathology , Collagen/genetics , Gene Expression Regulation, Neoplastic , Humans , Immunohistochemistry , In Situ Hybridization , Intervertebral Disc/embryology , Keratins/analysis , Lectins, C-Type , Lumbar Vertebrae/chemistry , Lumbar Vertebrae/embryology , Lumbar Vertebrae/pathology , Mucin-1/analysis , Phenotype , Proteoglycans/genetics , RNA, Messenger/genetics , RNA, Messenger/metabolism , S100 Proteins/analysis , Vimentin/analysis
4.
Acta Oncol ; 39(3): 429-36, 2000.
Article in English | MEDLINE | ID: mdl-10987242

ABSTRACT

The aim of this study was to present the target volume and irradiation technique in the most complex situation where the breast or chest wall and the locoregional lymphatics (mammaria interna lymph nodes, axillary and supraclavicular lymph nodes) have to be irradiated. The study comprised 125 breast cancer patients treated with curative intent after primary surgery in the last two years at our institute. In 62 cases the target volume included the breast or chest wall and the locoregional lymphatics, which were treated using our irradiation technique. The target conformal irradiation technique is a multiple non-opposed beams one isocenter technique developed to protect the heart and lungs. This technique, consisting of several rotation beams modulated with wedge filters and individual lung absorbers as well as additional fixed beams, was used in our study to apply a homogeneous dose of 46 to 56 Gy to the target volume; the irradiation technique was optimized by means of dose-volume histograms. After pre-localization, the patients underwent computerized tomographic scanning, with sections at 1.0 cm intervals. Contouring of target volume and organs at risk was carried out with a MULTIDATA workstation for regions of interest (mammaria interna and/or axillary and/or supraclavicular lymphatics and the breast or chest wall) as well as the organs at risk, such as heart and lung parenchyma. Planning target volume coverage was examined by three-dimensional isodose visualization for all CT axial sections for each patient. To determine the incidence of acute or late side effects on the lung parenchyma, conventional chest x-rays and CT studies were carried out at 1 month, 3 months and 6 months after completion of radiotherapy. Dose-volume histogram analysis revealed that this irradiation technique permits the application of a homogeneous dose to the target volume, conforming to the ICRU norms. The maximum dose applied to the ipsilateral lung parenchyma was less than 50-70% of the prescribed dose in the target volume. For left-located primaries, the highest dose applied to the myocardium is less than 30-50% of the dose in the target volume. Acute side effects, such as radiation pneumonitis, were noted in 8% (5/62) of the treated patients. Late side effects (grade I) in the lung were observed in 6.4% of the patients (4 patients) and occurred only in areas that had received more than 70% of the prescribed dose. We conclude that it is possible to apply a homogeneous dose distribution with a one isocenter multiple beams irradiation technique to the most complex target volume, such as the breast or chest wall and the locoregional lymphatics, with a minimum of side effects guaranteed.


Subject(s)
Breast Neoplasms/radiotherapy , Lymph Nodes/pathology , Lymphatic Irradiation/methods , Radiotherapy, Conformal/methods , Adult , Axilla , Breast Neoplasms/pathology , Breast Neoplasms/surgery , Dose Fractionation, Radiation , Female , Humans , Lymphatic Metastasis , Mastectomy , Radiotherapy, Adjuvant
5.
Eur J Biochem ; 267(10): 2965-72, 2000 May.
Article in English | MEDLINE | ID: mdl-10806395

ABSTRACT

Cathepsin L-like cysteine proteinases contain an evolutionarily highly conserved alpha-helical motif in the proregion. This is called the ER(F/W)N(I/V)N motif according to the conserved amino acids along one side of the helix. We studied the function of this motif using site-directed mutagenesis experiments of human procathepsin S. We replaced each of these amino acids with alanine and constructed deletion mutants lacking parts of the helix. All mutants were expressed in HEK 293 cells, but only one, W52A, was not processed to mature cathepsin S, nor was it phosphorylated or secreted into the culture medium. W52 is part of the hydrophobic core in the propeptide region of cathepsin S comprising two additional tryptophan residues, W28 and W31, also conserved among cathepsin L-like cysteine peptidases. Replacement of the latter with alanine led to consequences similar to those with the W52A mutation. Recombinant propeptides containing mutations of one of the three tryptophan residues were three orders of magnitude less effective as inhibitors of mature cathepsin S than the wild-type propeptide. The results point to a dominant role of the respective hydrophobic stack in the proper folding, transport and maturation of procathepsin S and related cathepsin L-like cysteine proteinases.


Subject(s)
Cathepsins/chemistry , Endopeptidases , Tryptophan/chemistry , Tryptophan/genetics , Amino Acid Sequence , Antigens, CD/metabolism , Blotting, Western , Cathepsin L , Cathepsins/biosynthesis , Cathepsins/genetics , Cathepsins/metabolism , Cell Line , Conserved Sequence , Cysteine Endopeptidases , DNA, Complementary/metabolism , Electrophoresis, Polyacrylamide Gel , Endoplasmic Reticulum/metabolism , Enzyme Precursors/biosynthesis , Evolution, Molecular , Humans , Kinetics , Lysosomal Membrane Proteins , Membrane Glycoproteins/metabolism , Microscopy, Fluorescence , Models, Molecular , Molecular Sequence Data , Mutagenesis, Site-Directed , Precipitin Tests , Protein Structure, Tertiary , Transfection
6.
Eur J Endocrinol ; 140(3): 250-5, 1999 Mar.
Article in English | MEDLINE | ID: mdl-10216521

ABSTRACT

The molecular mechanisms leading to increased cellular proliferation rates and, thus, tumor formation in the anterior pituitary gland are poorly understood. The cyclin-dependent kinase inhibitor p27Kip1 is a key molecule regulating the G1 phase of the cell cycle in many cell types. Furthermore, it was shown that p27 knock-out mice develop pro-opiomelanocortin-positive pituitary tumors. In an effort to clarify the role of p27 in the normal and tumorous human pituitary, we studied the expression of p27 by immunohistochemistry, using a highly specific mouse monoclonal anti-human p27 antibody. Normal pituitaries and 54 pituitary adenomas (twelve somatotrope adenomas, nine prolactinomas, twelve corticotrope adenomas, three TSH-producing tumors, six gonadotrope adenomas, six null cell adenomas, and six oncocytomas) were analyzed. p27 expression was determined semiquantitatively with regard to both the percentage of positive cells and the intensity of the staining. Normal human pituitaries showed strong expression of p27 in most nuclei. In contrast, the levels of p27 were reduced in the majority of the tumors analyzed. Twenty-two tumors (six somatotrope adenomas, five prolactinomas, four corticotrope adenomas, two TSH-producing tumors, two gonadotrope adenomas, and three null cell adenomas) were completely p27-negative. In 18 tumors, p27 expression was found in < or = 10% of the cells. In the other ten tumors, 11-80% of the cells were p27-positive. In summary, we were able to demonstrate reduced expression levels of the cell-cycle inhibitor p27 in tumors derived from all pituitary cell types. Our data indicate that p27 may be an important regulator of cellular proliferation in the anterior pituitary, the underexpression of which could play a role in pituitary tumorigenesis.


Subject(s)
Adenoma/genetics , Cell Cycle Proteins , Gene Expression Regulation, Developmental , Microtubule-Associated Proteins/genetics , Pituitary Neoplasms/genetics , Tumor Suppressor Proteins , Adenoma/metabolism , Antibodies, Monoclonal , Cyclin-Dependent Kinase Inhibitor p27 , Cyclin-Dependent Kinases/antagonists & inhibitors , Enzyme Inhibitors/chemistry , Humans , Immunohistochemistry , Microtubule-Associated Proteins/biosynthesis , Pituitary Gland/cytology , Pituitary Gland/pathology , Pituitary Neoplasms/metabolism
7.
Eur J Pediatr ; 158(4): 288-92, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10206125

ABSTRACT

UNLABELLED: We report the clinical course of a prepubertal girl with central diabetes insipidus (DI) and consequent panhypopituitarism evolving over a period of 10 years due to lymphocytic hypophysitis and subsequent germinoma. Two years after the diagnosis of central DI was established, MRI revealed a thickened pituitary stalk. Later pituitary enlargement and increasing thickening of the pituitary stalk impinging on the optic chiasm required a trans-sphenoidal biopsy which disclosed active hypophysitis with lymphocytic infiltrates and necrosis. High dose dexamethasone treatment only temporarily halted the disease process. Therefore, stereotactic radiation therapy was performed as a rescue treatment and MRI findings almost reversed. However, the subsequent MRI showed multiple intracranial lesions identified histologically as a germinoma and a standard chemotherapy and radiation was performed. CONCLUSION: The diagnosis of diabetes insipidus in children requires long-term follow up beyond the pubertal age in order to establish the underlying cause. In contrast to lymphocytic hypophysitis in adults, lymphocytic hypophysitis in prepubertal children may represent the first sign of a host reaction to an occult germinoma.


Subject(s)
Brain Neoplasms/complications , Diabetes Insipidus/etiology , Germinoma/complications , Hypopituitarism/etiology , Pituitary Diseases/complications , Brain Neoplasms/pathology , Brain Neoplasms/therapy , Child , Female , Germinoma/pathology , Germinoma/therapy , Humans , Pituitary Diseases/diagnosis , Pituitary Diseases/therapy
8.
Pituitary ; 1(3-4): 303-7, 1999 May.
Article in English | MEDLINE | ID: mdl-11081213

ABSTRACT

Case history, light and electron microscopic findings of a case of a lymphocytic hypophysitis in coincidence with a suprasellar germinoma in a 12-year-old girl are reported. The girl presented with a long time case history of diabetes insipidus and subsequent panhypopituitarism. Two years after the diagnosis of diabetes insipidus magnetic resonance imaging (MRI) showed a tumorous enlargement of the sellar content and pituitary stalk. A transnasal exploration was initially performed and revealed a lymphocytic hypophysitis. Light microscopy showed a dense infiltration of mature lymphocytes and plasma cells in the interstitium of the anterior pituitary gland. The stalk area could not be exposed to exclude a germinoma. One year later the lesion relapsed despite dexamethason therapy and a second operation by another neurosurgeon had to be performed. Light microscopy showed lymphocytic infiltrates, fibrosis and necrosis. The diagnosis was a lymphocytic hypophysitis again. Though transcranially exposed only pituitary tissue was removed. No infundibular mass became visible at surgery as shown by MRI. The girl developed five months later multiple cerebral lesions, which revealed to be a germinoma. Lymphocytic hypophysitis in children is very rare and a coincidence with a germinoma has not been described from histopathological aspect until now. The origin of the pituitary infiltration is discussed.


Subject(s)
Germinoma/complications , Lymphocytes/pathology , Pituitary Diseases/complications , Pituitary Diseases/pathology , Pituitary Neoplasms/complications , Child , Diabetes Insipidus/complications , Female , Germinoma/pathology , Humans , Hypopituitarism/complications , Inflammation/complications , Inflammation/pathology , Pituitary Gland, Anterior/pathology , Pituitary Neoplasms/pathology
9.
Exp Clin Endocrinol Diabetes ; 106(5): 425-30, 1998.
Article in English | MEDLINE | ID: mdl-9831310

ABSTRACT

A patient with a ganglioglioma of the neurohypophysis developed the syndrome of inappropriate antidiuretic hormone secretion (SIADH). We present the case and describe its microscopic and ultrastructural features. Malignant neoplasms were thought to be the main cause of ectopic production of vasopressin. Head trauma, infection, or drugs, however, can also induce hypersecretion of vasopressin. Mechanical compression of the pituitary stalk can lead to an excessive antidiuretic hormone (ADH) release by affecting the inhibitory system. Primary neuroendocrine tumors of the hypothalamic-neurohypophyseal system are extremely rare. We demonstrate the presence of vasopressin in the tumor cells by immunocytochemistry. This represents the first case of SIADH caused by a tumor of the neurohypophysis.


Subject(s)
Ganglioglioma/metabolism , Inappropriate ADH Syndrome/etiology , Pituitary Neoplasms/metabolism , Vasopressins/metabolism , Aged , Cell Nucleus/pathology , Cytoplasm/pathology , Ganglioglioma/complications , Ganglioglioma/pathology , Humans , Immunohistochemistry , Male , Microscopy, Electron , Pituitary Neoplasms/complications , Pituitary Neoplasms/pathology , Vasopressins/analysis
10.
J Pathol ; 169(3): 335-9, 1993 Mar.
Article in English | MEDLINE | ID: mdl-8492226

ABSTRACT

Pro-opiomelanocortin (POMC) mRNA was demonstrated in pituitary adenomas from 16 patients with Cushing's disease and 10 with Nelson's syndrome. The intensity of signal was significantly greater in Nelson's syndrome than in Cushing's disease and there was a trend towards a greater proportion of positive cells. This probably reflects inhibition of POMC gene expression by the high circulating levels of cortisol in Cushing's disease. In the para-adenomatous gland, the intensity of signal was variable in cells showing Crooke's hyaline change, ranging from negative to strongly positive, in keeping with the functional heterogeneity of corticotrophs. In one case, junctional corticotrophs were present and these were more intensely stained than anterior lobe corticotrophs in the same gland. This supports the concept that these cells are subject to different regulatory influences from corticotrophs in the anterior lobe. Whether this is related to differences in embryological origins or to local factors is at present unclear.


Subject(s)
Cushing Syndrome , Nelson Syndrome , Pituitary Neoplasms/chemistry , Pro-Opiomelanocortin/analysis , RNA, Messenger/analysis , Adenoma/chemistry , Cushing Syndrome/pathology , Gene Expression Regulation, Neoplastic , Humans , Nelson Syndrome/pathology , Pituitary Neoplasms/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...